Arkstone's AI Diagnostics Lead ARCHIMED's Latest Acquisition
Deal News | Aug 04, 2025 | Archimed SAS
ARCHIMED SAS, a private equity firm specializing in healthcare investments, has acquired a majority stake in Arkstone Medical Solutions. Arkstone, established in 2018 in Florida, leverages machine learning and generative AI to deliver Clinical Decision Support that enhances antimicrobial stewardship. The company’s OneChoice Report utilizes advanced analytics to optimize infectious disease treatment recommendations for healthcare providers. The investment aligns with ARCHIMED’s strategy to address public health challenges, reinforce its global healthcare IT and diagnostics portfolio, and expand Arkstone's international reach. This is ARCHIMED's third investment through its MED Rise fund, following investments in SeqCenter and FIM Medical, demonstrating its commitment to innovation and tackling global antimicrobial resistance.
Sectors
- Healthcare Technology
- Private Equity
Geography
- United States – Arkstone is based in Florida, making the United States a primary geography for the article.
Industry
- Healthcare Technology – The article focuses on healthcare technology, exemplified by Arkstone's use of machine learning and AI for clinical decision support.
- Private Equity – The industry context of private equity is represented by ARCHIMED's investment activities and healthcare sector focus.
Financials
- 10 million to 1 billion – The investment range for ARCHIMED's different fund lines, including the MED Rise fund involved in this acquisition.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| ARCHIMED SAS | Bidding Company | Companies | A private equity firm specializing in healthcare investments, recently acquiring a stake in Arkstone. |
| Arkstone Medical Solutions | Target Company | Companies | A healthcare technology company using AI to improve clinical decision-making and antimicrobial stewardship. |
| CARSO | Portfolio Company | Companies | A participant reflecting ARCHIMED's previous focus on public health issues through investment. |
| SeqCenter | Portfolio Company | Companies | A diagnostics company and one of Archimed's other investments through its MED Rise fund. |
| FIM Medical | Portfolio Company | Companies | A MedTech company and Archimed's portfolio company under the MED Rise fund. |